Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment
10.1007/s12017-020-08632-0
Saved in:
Main Authors: | Chua, Xin Ying, Ho, Leona TY, Xiang, Ping, Chew, Wee Siong, Lam, Brenda Wan Shing, Chen, Christopher P, Ong, Wei-Yi, Lai, Mitchell KP, Herr, Deron R |
---|---|
Other Authors: | ANATOMY |
Format: | Review |
Language: | English |
Published: |
HUMANA PRESS INC
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/188301 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications
by: Chong, Joyce R, et al.
Published: (2021) -
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment
by: Chua, Xin Ying, et al.
Published: (2021) -
Profiling brain and plasma lipids in human apoe ε2, ε3, and ε4 knock - In mice using electrospray ionization mass spectrometry
by: Sharman, M.J., et al.
Published: (2014) -
Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target
by: Sukocheva, OA, et al.
Published: (2021) -
Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs
by: Lai, Mitchell KP, et al.
Published: (2021)